Imricor Medical Systems, Inc. (ASX:IMR)

Imricor Medical Systems Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	616	367	96	55	144	284
Market Cap Growth	64.09%	281.62%	74.29%	-61.62%	-49.27%	155.25%
Enterprise Value	577	379	103	45	126	271
Last Close Price	1.92	1.36	0.55	0.35	0.97	2.19
PS Ratio	539.71	237.01	106.62	46.01	150.33	311.76
PB Ratio	17.50	-30.82	-7.50	5.00	4.67	7.60
P/TBV Ratio	17.50	-	-	5.00	4.67	7.60
EV/Sales Ratio	-	244.66	114.13	37.28	131.63	298.01
Debt / Equity Ratio	1.08	-2.88	-1.22	0.59	0.08	0.09
Asset Turnover	0.02	0.06	0.06	0.04	0.02	0.03
Inventory Turnover	1.13	1.18	0.88	0.96	0.92	0.51
Quick Ratio	25.34	6.81	0.27	2.80	6.81	11.03
Current Ratio	26.23	7.79	0.86	4.67	8.30	12.58
Return on Equity (ROE)	-432.29%	-	-	-116.05%	-77.05%	-69.44%
Return on Assets (ROA)	-38.22%	-68.06%	-95.73%	-53.19%	-41.90%	-33.90%
Return on Capital Employed (ROCE)	-36.10%	-84.60%	-450.70%	-148.50%	-84.00%	-38.20%
Earnings Yield	-8.90%	-13.06%	-34.47%	-46.23%	-18.85%	-5.69%
FCF Yield	-4.20%	-6.88%	-19.90%	-44.61%	-17.31%	-5.93%
Buyback Yield / Dilution	-57.17%	-43.03%	-7.46%	-11.42%	-18.76%	-81.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.